INDIANA UNIVERSITY SCIENTISTS REPORT GLEEVEC HOLDS POTENTIAL AS FIRST DRUG TO TREAT NEUROFIBROMATOSIS
October 30, 2008
October 30, 2008
INDIANAPOLIS, Oct. 30 -- Indiana University issued the following news release:
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
The research team is conducting clinical tests of the drug following successful laboratory tests and a "compassionate use" of the drug that show . . .
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now.
The research team is conducting clinical tests of the drug following successful laboratory tests and a "compassionate use" of the drug that show . . .